Adverse effect signature extraction and prediction for drugs treating COVID-19

Given the considerable cost of drug discovery, drug repurposing is becoming attractive as it can effectively shorten the development timeline and reduce the development cost. However, most existing drug-repurposing methods omitted the heterogeneous health conditions of different COVID-19 patients. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han, Wang, Xin, Li, Teng, Lai, Daoyuan, Zhang, Yan Dora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673014/
https://www.ncbi.nlm.nih.gov/pubmed/36406131
http://dx.doi.org/10.3389/fgene.2022.1019940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673014/
https://www.ncbi.nlm.nih.gov/pubmed/36406131
http://dx.doi.org/10.3389/fgene.2022.1019940

Ejemplares similares